Updated core competencies in pharmacoepidemiology to inform contemporary curricula and training for academia, government, and industry

• Vicki Osborne
• Amie J. GoodinUniversity of Florida
• Joshua David BrownPfizer (United States)
• Almut Gertrud WintersteinUniversity of Florida
• Andrew BateGlaxoSmithKline (United Kingdom)
• Catherine CohetEuropean Medicines Agency
• Lisa PontUniversity of Technology Sydney
• David G. MoenyUnited States Food and Drug Administration
• Olaf H. KlungelUtrecht University
• Simone P. PinheiroAbbVie (United States)
• John D. Seeger
• K. Arnold ChanNational Taiwan University
• Stanley A. EdlavitchUniversity of Missouri–Kansas City
• Hugh H. TilsonUniversity of North Carolina at Chapel Hill
• Deborah Layton